Jeremy Luban

Title: The Innovative Contributions of Jeremy Luban

Introduction

Jeremy Luban is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of antiviral agents. With a total of 4 patents to his name, Luban's work focuses on innovative solutions for combating viral infections.

Latest Patents

Luban's latest patents include groundbreaking inventions such as polynucleotides encoding a human TRIM-Cyp fusion polypeptide. This invention provides a nucleic acid that encodes a human TRIM-cyclophilin A fusion sequence, which is active as an anti-viral agent, specifically targeting HIV-1. Additionally, he has developed methods for treating or preventing viral infections by administering the nucleic acid, polypeptide, vector, or composition to subjects in effective amounts. Another notable patent involves a polynucleotide encoding a TRIM-cyp polypeptide, which also serves as an anti-viral agent.

Career Highlights

Jeremy Luban is affiliated with Columbia University, where he conducts research and develops innovative solutions in the field of virology. His work has garnered attention for its potential impact on public health, particularly in the fight against viral diseases.

Collaborations

Luban collaborates with esteemed colleagues such as David Sayah and Martha Neagu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jeremy Luban's contributions to the field of biotechnology and virology are noteworthy, as he continues to develop innovative solutions to combat viral infections. His work exemplifies the importance of research and collaboration in advancing medical science.